A pharmaco-toxicological evaluation of betulinic acid mixed with hydroxipropilgamma cyclodextrin on in vitro and in vivo models

Farmacia

Volumn 59, Issue 1, 2011, Pages 51-59

  Dehelean, Cristina A ^a   Soica, Codruta ^a   Peev, Camelia ^a   Ciurlea, Sorina ^a   Feflea, Stefana ^a   Kasa Jr , Peter ^b  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Betulinic acid; Cancer; Cyclodextrin; Skin pathology

Indexed keywords

BETULIC ACID; CYCLODEXTRIN; GAMMA CYCLODEXTRIN; PENTACYCLIC TRITERPENE;

ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL STRAIN MCF 7; CYTOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; ZYGOTE;

EID: 79951779702     PISSN: 00148237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Fulda S, Debatin KM, Betulinic acid induces apoptosis through a direct effect on mithocondria in neuroectodermal tumors, Medical and Pediatric Oncology, 2000, 35, 616-618;
2. Fulda S., Betulinic acid for cancer treatment and prevention, Int.J.Mol.Sci., 2008, 9, 1096-1107;
3. Rajendran P, Jaggy M., Singh M.K., Mukherjee R., Burman A.C., Pharmacological evaluation of C-3 modified betulinic acid derivates with potent anticancer activity, Invest. New Drugs 2008, 26:25-34;
4. Yogeeswari P., Sriram D., Betulinic acid and its derivates: a review of their biological properties, Current Medicinal Chemistry, 2005, 12:657-666. (Pubitemid 40331058)
5. Patocka J., Biologically active pentacyclic triterpenes and their current medicine signification, Journal of Applied Biomedicine, 2003, 1, 7-12;
6. Liby K., Honda T., Williams C.R., Risingsong R., Royce D.B., Suh N., Dinkova-Kostova A.T., Stephenson K.K., Talalay P., Sundararajan C., Gribble G.W., Sporn M.B., Novel semisynthetic analogues for betulinic acid with diverse cytoprotective, antiproliferative and proapototic activities, Mol.Cancer Ther., 2007, 6(7), 2113-2119;
7. Liu W.K., Ho JCK, Cheung FWK, Liu BPL, Ye WC, Che CT, Apoptotic activity of betulinic acid derivates on murine melanoma B16 cell line, European Journal of Pharmacology, 2004, 498, 71-78;
8. Dehelean C., Soica C., Peev C., Gruia A.T., Seclaman E., Physico-chemical and molecular analysis of antitumoral pentacyclic triterpenes in complexation with gammacyclodextrin, Revista de Chimie, 2008, 59(8), 887-890;
9. Szejtli J., Introduction and General Overview of Cyclodextrin Chemistry. Chem.Rev., 1998, 98(5), 1743-1754;
10. Larue L., Beermann F., Cutaneous melanoma in genetically modified animals, Pigment Cell, Res., 2007, 20, 485-497;
11. Boukamp P., Non-melanoma skin cancer: what drives tumor development and progression?, Carcinogenesis, 2005, 26(10), 1657-1667;
12. Higuchi T., Connors K., Phase solubility techniques, Adv. Anal. Chem Instrum., 1965, 4, 117-212;
13. Şoica C.M., Dehelean C.A., Peev C., Coneac G., Gruia T.A., Complexation with hydroxipropilgammacyclodextrin of some pentacyclic triterpenes. Characterisation of their binary products, Farmacia, 2008, vol. LVI, 2, 182-190;
14. Ribatti D., Nico B., Vacca A., Presta M., The gelatin sponge-chorioallantoic membrane assay. Nat Protoc., 2006, 1(1), 85-91;
15. Mosmann T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J Immunol Methods 1983, 65: 55-63;
16. Feflea S, Dehelean C, Peev C, Soica C., Ceausu R, Gaje P, Betulinic acid and betulin: implications in the angiogenesis process of the chorioallantoic membrane, Revista de Medicinǎ şi Farmacie Tirgu-Mures - Orvosi es Gyogyszereszeti Szemle, 2009, 55, 346-349;
17. Chintharlapalli S, Papineni S, Ramaiah S K, Betulinic Acid Inhibits Prostate Cancer Growth through Inhibition of Specificity Protein Transcription Factors, Cancer Res., 2007, 7(6), 2816-2823;
18. Pisha E., Chai H., Lee I.S., Chagwedera T.E., Farnsworth N.R., Cordell G.A., Beecher C.W., Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat Med, 1995, 1, 1046-1051.